Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04184050
Title A Phase 1/2 Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and PK of HPN217 in Patients With R/R MM
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Harpoon Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | ESP | DEU


No variant requirements are available.